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Edited by Felix WielandAbstract We investigated the signaling pathways participating
in hyperosmotic regulation of the human taurine transporter
(TAUT) by using speciﬁc inhibitors of various intracellular
signaling molecules. Among them, the speciﬁc inhibitor of
calcium/calmodulin-dependent protein kinase II (Ca2þ/CaM
kinase II) completely repressed the hyperosmotic regulation of
TAUT. The osmosensitive upregulation of TAUT was also
signiﬁcantly inhibited by calmodulin antagonists and calcium-
chelators. The increased expression level of TAUT mRNA by
hypertonicity was repressed by the speciﬁc Ca2þ/CaM kinase II
inhibitor. The activated form of Ca2þ/CaM kinase II protein
could only be detected in Caco-2 cells under hypertonic
conditions.
 2004 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Caco-21. Introduction
Extracellular hypertonicity is balanced by maintaining a
high intracellular content of non-perturbing osmolytes like
betaine, myo-inositol, glycerophosphorylcholine, sorbitol, and
taurine in mammalian cells [1]. The intracellular accumulation
of such osmolytes as betaine, myo-inositol, and taurine is
performed by betaine/c-amino-n-butyric acid transporter 1
(BGT1), the myo-inositol transporter (SMIT), and the taurine
transporter (TAUT) [2]. It has been found in many cells that
hypertonicity induced the activity and expression level of these* Corresponding author. Fax: +81-3-5841-8026.
E-mail address: asatsu@mail.ecc.u-tokyo.ac.jp (H. Satsu).
Abbreviations: AR, aldose reductase; BGT1, betaine/c-amino-n-butyric
acid transporter 1; Ca2þ/CaM kinase II, calcium/calmodulin-depen-
dent protein kinase II; CREB, cAMP-responsive element-binding
protein; DIDS, 4,40-diisothiocyanostilbene-2,20-disulfonic acid;
DMEM, Dulbecco’s modiﬁed Eagle’s medium; ERK, extracellular
signal-regulated kinase; Et-18-OCH3, 1-O octadecyl-2-O-methyl-rac-
glycero-3-phosphorylcholine; FCS, fetal calf serum; HBSS, Hank’s
balanced salt solution; JNK, Jun N-terminal kinase; LPC, lysophos-
phatidylcholine; MAP kinase, mitogen-activated protein kinase; PBS,
phosphate-buﬀered saline; PDTC, pyrrolidine dithiocarbamate; PKA,
protein kinase A; PKC, protein kinase C; SMIT, myo-inositol
transporter; TAUT, taurine transporter
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doi:10.1016/j.febslet.2004.05.062osmolyte transporters [3]. Aldose reductase (AR), which is
involved in the synthesis of sorbitol from glucose, is also
known to be upregulated under hypertonic conditions [4], such
an osmotic response being performed to maintain the cell
volume against exposure to a hypertonic environment.
The osmotic regulation of osmolyte transporters and
synthetic enzymes has been studied in several tissues [5–7].
Since the small intestine, especially the intestinal epithelial
cells, and the kidney mudulla are exposed to extreme changes
of hypertonicity, we have previously reported that taurine
would be likely to behave as an osmolyte and that hyperto-
nicity stimulated the activity and gene expression of TAUT in
human intestinal Caco-2 cells [8] and the rat small intestine [9].
We have also reported the osmoregulation of TAUT and
cysteine dioxygenase, one of the key enzymes of taurine bio-
synthesis, in a human hepatic HepG2 cell line [10].
Although the intracellular signaling pathways leading to the
upregulation of several osmolyte transporters and synthetic
enzymes have recently been investigated, the intracellular
regulatory mechanism of TAUT under hypertonic conditions
has not yet been elucidated. In mammalian cells, hypertonicity
induces three enzymes in the mitogen-activated protein kinase
(MAP kinase) family: extracellular signal-regulated kinase
(ERK), Jun N-terminal kinase (JNK), and p38 [11,12]. Studies
on the relationship between the MAP kinase pathway and
osmotic regulation of BGT1, SMIT, and AR have been re-
ported [13–19], although there has not yet been any report
about the signal cascade including MAP kinase that is in-
volved in the osmoregulation of TAUT.
We investigated in the present study the signaling pathway
involved in the hyperosmotic induction of human TAUT in
human intestinal Caco-2 cells. Speciﬁc inhibitors of various
intracellular signaling molecules, including the MAP kinase
family, were utilized in this analysis.2. Materials and methods
2.1. Materials
The Caco-2 cell line was obtained from American Type Culture
Collection (Rockville, MD, USA). Dulbecco’s modiﬁed Eagle’s me-
dium (DMEM) was purchased from Nissui Pharmaceuticals (Tokyo,
Japan) and fetal calf serum (FCS) was from Gibco (Gaithersburg,
MD, USA). [1,2-3H] taurine (speciﬁc radioactivity of 29 Ci/mmol) and
[a-32P] dCTP were from Amersham Pharmacia Biotech (Little Chal-
font, England). PD98059, SB203580, wortmannin, 1-O octadecyl-2-O-
methyl-rac-glycero-3-phosphorylcholine (Et-18-OCH3), rapamycin,blished by Elsevier B.V. All rights reserved.
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124 H. Satsu et al. / FEBS Letters 569 (2004) 123–128KN-62, KN-93, W-7, and calmidazolium were all purchased from
CAL Biochemicals (San Diego, CA, USA). 4,40-Diisothiocyanostil-
bene-2,20-disulfonic acid (DIDS) was from Sigma (St. Louis, MO,
USA) and the anti-active Ca2þ/CaM kinase II polyclonal antibody was
purchased from Promega (Madison, WI, USA).
2.2. Cell culture
Caco-2 cells were cultured with a medium consisting of DMEM,
10% FCS, 1% non-essential amino acids, 2% glutamine, 100 U/ml of
penicillin, 100 lg/ml of streptomycin and an appropriate amount of
sodium bicarbonate. The cells were incubated at 37 C under a hu-
midiﬁed atmosphere of 5% CO2 in air. The uptake experiments used
Caco-2 cells cultured in 24-well plates that had been precoated with
collagen at a density of 1.4 105 cells/well, cell monolayers being taken
after 14 days of culture.
2.3. Uptake experiments
The uptake experiments have been described previously [20]. The
[3H] taurine uptake experiments were performed in the absence (total
uptake) or presence (non-speciﬁc uptake) of 50 mM unlabeled taurine,
this allowing the speciﬁc uptake to be calculated by subtraction. The
Caco-2 monolayers were washed twice for 5 min with 700 ll of Hank’s
balanced salt solution (HBSS) containing 4 mM sodium bicarbonate
and 10 mM HEPES, the pH value being adjusted to 7.4 with KOH
(uptake buﬀer). The cells were next incubated with 0.3 lCi of [3H]
taurine in 300 ll of the uptake buﬀer, with or without excess (50 mM)
taurine, at 37 C for 10 min. At the end of the incubation period, the
buﬀer was removed and each monolayer was carefully washed three
times with 700 ll of ice-cold phosphate-buﬀered saline (PBS) con-
taining 0.05% sodium azide for 5 min. To each well was then added 250
ll of 0.1% Triton X-100, before the dissolved cells were taken into 3 ml
of a scintillation cocktail. The tritium content of each monolayer was
ﬁnally determined with an LSC 5100 liquid scintillation analyzer
(Aloka, Tokyo, Japan).
2.4. Northern blot analysis
Five lg of poly(Aþ) RNA fractionated on 1% agarose gel containing
2.2 M formaldehyde was transferred to a nylon ﬁlter (Hybond-N;
Amersham) according to the manufacturer’s instructions. The ﬁlter
was hybridized with the RT-PCR product of the human taurine
transporter and labeled by random priming with an [a-32P] dCTP
labeling kit (Multiprime; Amersham). After treating in a hybridization
solution (Rapid; Amersham) at 65 C for 3 h, the ﬁlter was washed in
0.1NaCl/Cit containing 0.1% SDS at 65 C.
2.5. Detection of activated Ca2þ/CaM kinase II by a Western blot
analysis
Caco-2 cells cultured in 6-well plates for 14 days were washed twice
with ice-cold PBS. The cells were scraped oﬀ and then homogenized
with a buﬀer containing 20 mM Tris–HCl (pH 8.0), 2 mM EDTA,
2 mM EGTA, 2 mM DTT, 1% NP-40, 1 mM PMSF, 1 lg/ml of
leupeptin, 10 lg/ml of pepstatin A, and 1 mM sodium orthovanadate.
The homogenate was incubated for 20 min at 4 C and then cen-
trifuged at 12 000 g for 20 min at 4 C. The supernatant was
fractionated by SDS/10% PAGE and transferred to a PVDF mem-
brane (Millipore). The membrane was blocked overnight at 4 C by
PBS-T containing 5% non-fat dried milk. The membrane was then
incubated for 2 h with the anti-active Ca2þ/CaM kinase II antibody
(1:1000 dilution). The blot was washed in PBS-T and incubated for
1 h with goat anti-rabbit IgG-HRP (1:2500 dilution). A chemilumi-
nescent substrate (ECL; Amersham Biosciences) was used for
detection.
2.6. Statistical analysis
Each result is expressed as the mean S.E. Diﬀerences among the
experimental data were assessed by ANOVA.
+KN-93-KN-93
Fig. 1. Eﬀect of various inhibitors on the hypertonicity-induced up-
regulation of the taurine uptake by Caco-2 monolayers. Caco-2 cells,
which had been cultured for 14 days, were incubated with (A)
PD98059 (20 lM), (B) SB203580 (20 lM), or (C) KN-93 (5 lM) for 3
h, and further incubated for 48 h in a hypertonic (containing 100 mM
raﬃnose; H) or isotonic medium (I) in the presence or absence of an
inhibitor. The uptake experiments were then performed as described in
Section 2. Each value is the mean S.E.M. ðn ¼ 6Þ, P < 0:01.3. Results
3.1. Eﬀect of speciﬁc inhibitors of the intracellular signaling
molecule on the hyperosmotic regulation of TAUT
Among various inhibitors of the intracellular signaling
molecule, we ﬁrst examined the eﬀect of PD98059, the MEK-speciﬁc inhibitor, and of SB203580, the speciﬁc inhibitor of
p38, on hypertonicity-induced upregulation of the taurine
uptake in Caco-2 cells. The cells were incubated with a medium
containing PD98059 (20 lM) or SB203580 (20 lM) for 3 h and
further cultured for 48 h with or without 100 mM raﬃnose in
the presence of PD98059 or SB203580. However, neither
PD98059 (20 lM) nor SB203580 (20 lM) had any eﬀect on the
osmotic regulation of TAUT in Caco-2 cell monolayers
(Fig. 1A and B).
200(A) b
H. Satsu et al. / FEBS Letters 569 (2004) 123–128 125Various speciﬁc inhibitors of such intracellular signaling
molecules as PI3-kinase (wortmannin), phospholipase C (Et-
18-OCH3), Ca2þ/CaM kinase II (KN-93), and mTOR signal-
ing (rapamycin) were tested for the osmotic regulation of
taurine uptake in Caco-2 cells. Among these, the treatment
with KN-93 at 5 lM signiﬁcantly blocked the hypertonicity-
induced upregulation of taurine uptake (Fig. 1C), whereas the
other inhibitors had no signiﬁcant eﬀect (data not shown).
3.2. Dose-dependent eﬀect of the Ca2þ/CaM kinase II inhibitors
on the osmotic regulation of TAUT
Fig. 2A shows that the hypertonicity-induced TAUT activity
decreased as the concentration of KN-93 was increased, and
that the treatment with KN-93 at 10 lM completely blocked
the osmotic induction of TAUT. The eﬀect of KN-62, another
Ca2þ/CaM kinase II inhibitor, on the osmotic regulation of
TAUT in Caco-2 cells was also studied. As shown in Fig. 2B,
KN-62 signiﬁcantly repressed the hypertonicity-induced up-
regulation of TAUT in a concentration-dependent manner and
completely blocked the hypertonicity-induced upregulation of0
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Fig. 2. Inhibitory eﬀect of Ca2þ/CaM kinase II inhibitors on the os-
mosensitive upregulation of TAUT activity in Caco-2 monolayers.
Caco-2 cells were incubated with (A) 1, 5, or 10 lM of KN-93 or (B)
0.5, 1, or 5 lM of KN-62 for 3 h, and further incubated for 48 h in a
hypertonic (containing 100 mM raﬃnose; H) or isotonic medium (I) in
the presence or absence of KN-93 or KN-62. The uptake experiments
were performed as described in Section 2. Each value is the mean
S.E.M. ðn ¼ 6Þ, P < 0:01.TAUT in Caco-2 cells at a concentration of 5 lM. These re-
sults suggest that Ca2þ/CaM kinase II was involved in the
hypertonicity-induced upregulation of TAUT in intestinal
epithelial Caco-2 cells.
3.3. Eﬀect of the calmodulin antagonist and EGTA on the
hyperosmotic regulation of TAUT
Cells were treated with the calmodulin antagonist, W-7 or
calmidazolium, to suppress the Ca2þ/CaM kinase II activation.
Exposure to W-7 (at 20 lM) and to calmidazolium (at 10 lM)
each signiﬁcantly repressed the activation of TAUT activity
under hypertonic conditions (Fig. 3A). The eﬀect of the cal-
cium-chelating reagent, EGTA, on the osmotic regulation of
TAUT was also investigated. Caco-2 cells were incubated with
5 mM EGTA for 3 h and further cultured for 48 h with or
without 100 mM raﬃnose in the presence of EGTA. Fig. 3B
shows that the EGTA treatment completely blocked the hy-0
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Fig. 3. Eﬀect of the Ca2þ/calmodulin antagonist and EGTA on the
upregulation of taurine uptake by hypertonicity. (A) Caco-2 cells were
incubated with the Ca2þ/calmodulin antagonist, W-7 (20 lM), and
calmidazolium (10 lM) for 3 h, and further incubated for 48 h in a
hypertonic (containing 100 mM raﬃnose; H) or isotonic medium (I) in
the presence or absence of the antagonist. Uptake experiments were
then performed as described in Section 2. Each value is the mean-
S.E.M. ðn ¼ 6Þ. (B) Caco-2 cells were incubated with 5 mM EGTA
for 3 h and further incubated for 48 h with a hypertonic (containing
100 mM raﬃnose; H) or isotonic medium (I) in the presence or absence
of EGTA. Uptake experiments were performed as described in Section
2. Each value is the meanS.E.M. ðn ¼ 6Þ, P < 0:01.
Fig. 5. Northern blot analysis of TAUT mRNA from Caco-2 cells
cultured in the hypertonic medium with or without KN-93. Caco-2
cells were pre-cultured with 10 lMKN-93 for 3 h and further cultured
(I) without or (H) with 100 mM raﬃnose for 48 h in the presence of
KN-93. A 10 lg amount of poly(A)þ RNA isolated from the Caco-2
cells was subjected to a Northern blot analysis. b-Actin was used as the
control.
126 H. Satsu et al. / FEBS Letters 569 (2004) 123–128pertonicity-induced upregulation of TAUT activity. The pos-
sible involvement of Ca2þ/CaM kinase II in the osmotic reg-
ulation of TAUT in Caco-2 cells was thus demonstrated.
3.4. Involvement of Ca2þ/CaM kinase II in the osmotic
regulation of TAUT in HepG2 cells
The results of our recent study have shown that hyperto-
nicity induced TAUT activity in a human hepatoblastoma
HepG2 cell line [10]. Experiments were performed to reveal
whether Ca2þ/CaM kinase II would also be involved in the
osmoregulation of TAUT in HepG2 cells or not. Fig. 4A
shows that KN-93 also signiﬁcantly repressed the hypertonic-
ity-induced upregulation of TAUT activity, whereas SB203680
had no signiﬁcant eﬀect (Fig. 4B). This result suggests that
Ca2þ/CaM kinase II, but not p38 MAP kinase, was involved in
the osmotic regulation of TAUT in human hepatoma HepG2
cells, like that in Caco-2 cells.Ta
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Fig. 4. Eﬀect of KN-93 on the hypertonicity-induced TAUT activation
in human hepatoma HepG2 cells. HepG2 cells were incubated with (A)
KN-93 (10 lM) or (B) SB203580 (20 lM) for 3 h, and further incu-
bated for 48 h in a hypertonic (containing 100 mM raﬃnose; H) or
isotonic medium (I) in the presence or absence of the inhibitor. Uptake
experiments were performed as described in Section 2. Each value is
the mean S.E.M. ðn ¼ 6Þ, P < 0:01.3.5. Eﬀect of Ca2þ/CaM kinase II inhibitors on the expression
of TAUT mRNA
The expression levels of TAUT mRNA in hypertonic and
isotonic cells were examined in the presence of KN-93. Human
TAUT cDNA obtained by RT-PCR was used as a probe to
perform a Northern blot analysis. Five lg of poly(A)þ RNA
extracted from Caco-2 cells that had been cultured in a hy-
pertonic or isotonic medium for 48 h with or without KN-93
was used. Fig. 5 shows that the mRNA level was markedly
higher in the cells that had been cultured with the hypertonic
medium than in those with the isotonic medium. In the pres-
ence of KN-93, however, the expression level of TAUT mRNA
was not increased, even in the hypertonic cells, its expression
level being similar to that in the isotonic cells (Fig. 5). This
result supports the possibility of the participation of Ca2þ/
CaM kinase II in the osmoregulation process. It also suggests
that the Ca2þ/CaM kinase II pathway acted upstream of
TAUT gene expression in this osmotic regulation.
3.6. Detection of activated Ca2þ/CaM kinase II in Caco-2 cells
under hypertonic conditions
The expression of Ca2þ/CaM kinase II mRNA could be
constitutively detected by RT-PCR (data not shown). We then
examined whether the Ca2þ/CaM kinase II protein would be
activated under hypertonic conditions or not.
A protein extract was collected every 2 h from Caco-2 cells
cultured under either hypertonic or isotonic conditions and
served for a Western blot analysis with the anti-active Ca2þ/
CaM kinase II antibody. This antibody could only detect the
activated form of the Ca2þ/CaM kinase II protein. As shown
in Fig. 6, activated Ca2þ/CaM kinase II was detected in Caco-2
cells that had been cultured for 11 h under hypertonic condi-
tions. This result conﬁrms that the Ca2þ/CaM kinase II proteinFig. 6. Detection of activated Ca2þ/calmodulin-dependent protein ki-
nase II in Caco-2 cells cultured under hypertonic conditions. Caco-2
cells were cultured (I) without or (H) with 100 mM raﬃnose for 11 h.
The cells were then scraped oﬀ and a protein extract was prepared. A
100 lg amount of this protein extract was subjected to a Western blot
analysis as described Section 2. The activated Ca2þ/CaM kinase II
protein was detected at approximately 52 kDa.
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testinal Caco-2 cells.4. Discussion
We investigated in the present study the osmotic regulation
of human TAUT in terms of the intracellular signaling path-
way and revealed for the ﬁrst time that the activation of Ca2þ/
CaM kinase II was involved in the hypertonicity-induced up-
regulation of human TAUT.
It is not yet understood as to how the cells adapted to a
change in extracellular osmolarity that led to the regulation
of osmolyte transporters or synthetic osmolyte enzymes
through the signal transduction pathway. However, several
studies on signal transduction in the regulation of osmolyte
transporters or synthetic enzymes have been reported, par-
ticularly in relation to the MAP kinase family [15–19]. Kwon
et al. [15], who used MDCK cells cultured in a hypertonic
medium, have reported that the transcription of genes re-
sponsible for the active transport of myo-inositol (SMIT) and
betaine (BGT1) was markedly stimulated, resulting in an
increase in SMIT and BGT1 mRNA, which in turn was
followed by the increased activity of osmolyte transport.
ERK, one of the MAP kinase family, was also stimulated in
a PKC-dependent manner in hypertonic MDCK cells.
However, SMIT and BGT1 mRNA were increased in hy-
pertonic MDCK cells, whereas the activation of ERK was
completely repressed by the downregulation of PKC. This
result indicates that the activation of ERK was not involved
in the transcriptional regulation of SMIT and BGT1 by hy-
pertonicity. Furthermore, Kultz et al. [16] have reported that
the osmoregulation of AR was accompanied by an increase in
the transcription of the aldose reductase gene in PAP-HT25
cells. Hypertonicity also stimulated the activation of JNK
and p38 in PAP-HT25 cells. However, they found that the
activation of JNK or p38 was not necessary for the tran-
scriptional regulation of AR by using PAP-HT25 cells
transfected with the dominant negative JNK, SEK1-AL, or
with the dominant negative p38 kinase, MKK3-AL. On the
other hand, it has been reported that hypertonic exposure of
human monocytes and macrophages led to the upregulation
of BGT1 and SMIT in their mRNA levels, as well as to an
increase in the betaine and myo-inositol uptake, and that this
upregulation was signiﬁcantly inhibited by SB203580, indi-
cating that the activation of p38 was involved in the hyper-
osmolarity-induced upregulation of osmolyte transporters
BGT-1 and SMIT [17]. Sheih-Hamad et al. [18] have also
reported that p38 kinase activity was essential for the osmotic
induction of BGT1 mRNA in MDCK cells. Our results show
that neither PD98059 nor SB203580 inhibited the hyperto-
nicity-induced upregulation of TAUT activity (Fig. 1A and
B), suggesting that neither the ERK nor p38 pathway was
involved in the osmotic regulation of human TAUT in Caco-
2 cells. It is therefore presumed that the intracellular signal
cascade involved in osmoregulation would be diﬀerent among
the osmosensitive genes; i.e., p38 kinase would be essential
for BGT1 and SMIT, but not for TAUT.
The eﬄux of taurine from the cells was also important when
considering the intracellular content of taurine, although the
eﬄux pathway for taurine has not yet been revealed. It has
been reported for NIH3T3 mouse ﬁbroblasts that the taurineeﬄux was signiﬁcantly inhibited by 4,40-diisothiocyanostil-
bene-2,20-disulfonic acid (DIDS), a speciﬁc inhibitor of the
chloride channel, suggesting that the eﬄux of taurine was
partly performed via the chloride channel [21,22]. Further-
more, the eﬀect of the calmodulin antagonist, W-7, on swell-
ing-induced taurine release has been reported, its eﬀect being
diﬀerent among cell types. For example, the swelling-induced
taurine release from Ehrlich cells and HeLa cells was inhibited
in the presence of W-7 [22], whereas the taurine eﬄux from
NIH-3T3 cells was potentiated by W-7 [21,23]. This opposing
eﬀect of W-7 is presumed to be due to the diﬀerence in tissues
and species. In human intestinal Caco-2 cells, the eﬄux activity
of taurine in response to a hypotonic milieu was also inhibited
by DIDS. However, W-7 and KN-93 had no signiﬁcant eﬀect
on the eﬄux activity of TAUT (data not shown), suggesting
that activation of the Ca2þ/CaM kinase II cascade was initially
involved in the taurine uptake and not in the taurine eﬄux in
our present study.
The regulation of TAUT and its regulatory mechanism have
been extensively investigated [24]. The upregulation of TAUT
was observed under hypertonic conditions at the transcrip-
tional level in several tissues, including intestinal epithelial cells
(Fig. 5, [8,24]). Furthermore, the regulation of TAUT by such
cytokines as TNF-a has also been reported, this regulation
being performed at the transcriptional level [25]. On the other
hand, TAUT was also regulated by protein kinase C at the
post-translational level [26]. It has also been revealed that Ser-
322 was a critical site for PKC regulation of the MDCK cell
taurine transporter (pNCT) [27]. The activity of TAUT in in-
testinal epithelial cells has also been reported to be inhibited by
lysophosphatidylcholine (LPC), the interaction of LPC with
TAUT in the intestinal cell membrane being the cause of the
reduced taurine uptake [28,29]. As shown in Fig. 5, TAUT
mRNA was increased under hypertonic conditions. However,
this result does not preclude the possibility of post-transcrip-
tional regulation by hypertonicity; for example, the taurine
uptake under hypertonic conditions may also include cellular
traﬃcking of the transporter between the cytosol and plasma
membrane, like the case of insulin-induced translocation of
GLUT4 in the muscle and adipocyte [30,31]. More detailed
experiments are needed to elucidate the mechanism for the
osmoregulation of human TAUT via the activation of Ca2þ/
CaM kinase II.
Ca2þ/CaM kinases are the most extensively characterized
kinases to be directly modulated by calmodulin [32]. It is now
understood that the Ca2þ/CaM kinase family has six isoforms
(types I–VI), type II Ca2þ/CaM kinase being one of the most
characterized enzymes among them. Ca2þ/CaM kinase II and
the isozymes are strongly expressed in the brain, and are also
expressed in most other tissues, including the small intestine
[33,34]. This kinase has been reported to play vital roles in such
functions as hippocampal long-term potentiation/memory
[32,35] and insulin exocytosis [36,37], and is therefore called a
‘‘multifunctional protein kinase’’ [32]. The speciﬁc inhibitor of
Ca2þ/CaM kinase II completely repressed the increased ex-
pression level of TAUT mRNA by hypertonicity (Fig. 5),
suggesting that the activation of Ca2þ/CaM kinase II partici-
pated upstream of the transcriptional regulation of TAUT. A
cyclic AMP-responsive element-binding protein (CREB), a
transcriptional factor which is activated via the protein kinase
A (PKA) pathway, is involved in these functions as a substrate
of Ca2þ/CaM kinase II [32,38]. We therefore hypothesize a
128 H. Satsu et al. / FEBS Letters 569 (2004) 123–128pathway by which hypertonicity led to the activation of Ca2þ/
CaM kinase II, and subsequent modulation of CREB that
induced an increase in TAUT gene expression and ﬁnally
increased the taurine uptake by Caco-2 cells. However,
Br-cAMP exposure, which had been presumed to induce the
activation of PKA and CREB, had no signiﬁcant eﬀect on the
taurine uptake by Caco-2 cells (data not shown). This result
suggests that the modulation of CREB was not involved in this
Ca2þ/CaM kinase II-dependent osmoregulation of taurine
uptake. We have recently cloned the promoter region of hu-
man TAUT and found the consensus element of AP-1 and
nuclear factor-jB (NF-jB) in the promoter region. AP-1 and
NF-jB may therefore be candidates for the signal cascade
existing between Ca2þ/CaM kinase II activation and the in-
creased expression of TAUT mRNA.
In conclusion, the involvement of Ca2þ/CaM kinase II in the
hypertonicity-induced upregulation of human TAUT was
demonstrated for the ﬁrst time in this work. This result will
provide more information for understanding the mechanism
for the intracellular regulation of TAUT under hypertonic
conditions, as well as a new function of Ca2þ/CaM kinase II in
cellular regulation.
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